The Effects of Liraglutide on Sudomotor Function and Inflammation in Type 2 Diabetes

NCT03426085 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

44

Enrollment

OTHER

Sponsor class

Conditions

Autonomic Nervous System Diseases
Sweat Gland Diseases
Diabetic Neuropathy With Neurologic Complication

Interventions

DRUG: Liraglutide 6 mg Solution for Injection
OTHER: Placebo

Sponsor

Eastern Virginia Medical School